131 related articles for article (PubMed ID: 31970441)
1. Resveratrol prevents diabetic nephropathy by reducing chronic inflammation and improving the blood glucose memory effect in non-obese diabetic mice.
Xian Y; Gao Y; Lv W; Ma X; Hu J; Chi J; Wang W; Wang Y
Naunyn Schmiedebergs Arch Pharmacol; 2020 Oct; 393(10):2009-2017. PubMed ID: 31970441
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of umbilical cord mesenchymal stem cells combined with resveratrol against renal podocyte damage in NOD mice.
Xian Y; Lin Y; Cao C; Li L; Wang J; Niu J; Guo Y; Sun Y; Wang Y; Wang W
Diabetes Res Clin Pract; 2019 Oct; 156():107755. PubMed ID: 31150720
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway.
He T; Xiong J; Nie L; Yu Y; Guan X; Xu X; Xiao T; Yang K; Liu L; Zhang D; Huang Y; Zhang J; Wang J; Sharma K; Zhao J
J Mol Med (Berl); 2016 Dec; 94(12):1359-1371. PubMed ID: 27488452
[TBL] [Abstract][Full Text] [Related]
4. 6-Shogaol ameliorates diabetic nephropathy through anti-inflammatory, hyperlipidemic, anti-oxidative activity in db/db mice.
Xu Y; Bai L; Chen X; Li Y; Qin Y; Meng X; Zhang Q
Biomed Pharmacother; 2018 Jan; 97():633-641. PubMed ID: 29101807
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
Liang G; Song L; Chen Z; Qian Y; Xie J; Zhao L; Lin Q; Zhu G; Tan Y; Li X; Mohammadi M; Huang Z
Kidney Int; 2018 Jan; 93(1):95-109. PubMed ID: 28750927
[TBL] [Abstract][Full Text] [Related]
7. Effect of resveratrol and rosuvastatin on experimental diabetic nephropathy in rats.
Hussein MM; Mahfouz MK
Biomed Pharmacother; 2016 Aug; 82():685-92. PubMed ID: 27470412
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H
Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619
[TBL] [Abstract][Full Text] [Related]
9. Zingerone attenuates diabetic nephropathy through inhibition of nicotinamide adenine dinucleotide phosphate oxidase 4.
Cui Y; Shi Y; Bao Y; Wang S; Hua Q; Liu Y
Biomed Pharmacother; 2018 Mar; 99():422-430. PubMed ID: 29367111
[TBL] [Abstract][Full Text] [Related]
10. Akebia Saponin D ameliorated kidney injury and exerted anti-inflammatory and anti-apoptotic effects in diabetic nephropathy by activation of NRF2/HO-1 and inhibition of NF-KB pathway.
Lu C; Fan G; Wang D
Int Immunopharmacol; 2020 Jul; 84():106467. PubMed ID: 32344355
[TBL] [Abstract][Full Text] [Related]
11. Alantolactone mitigates renal injury induced by diabetes via inhibition of high glucose-mediated inflammatory response and macrophage infiltration.
Zhu Y; Ling Y; Wang X
Immunopharmacol Immunotoxicol; 2020 Apr; 42(2):84-92. PubMed ID: 32064988
[No Abstract] [Full Text] [Related]
12. 3'-
Pérez Gutierrez RM; García Campoy AH; Paredes Carrera SP; Muñiz Ramirez A; Mota Flores JM; Flores Valle SO
Molecules; 2019 Mar; 24(7):. PubMed ID: 30925713
[TBL] [Abstract][Full Text] [Related]
13. Effect of
Wan F; Ma F; Wu J; Qiao X; Chen M; Li W; Ma L
Anal Cell Pathol (Amst); 2022; 2022():7847135. PubMed ID: 35132370
[No Abstract] [Full Text] [Related]
14. Attenuation of inflammatory response by a novel chalcone protects kidney and heart from hyperglycemia-induced injuries in type 1 diabetic mice.
Fang Q; Wang J; Wang L; Zhang Y; Yin H; Li Y; Tong C; Liang G; Zheng C
Toxicol Appl Pharmacol; 2015 Oct; 288(2):179-91. PubMed ID: 26206226
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats.
Elbe H; Vardi N; Esrefoglu M; Ates B; Yologlu S; Taskapan C
Hum Exp Toxicol; 2015 Jan; 34(1):100-13. PubMed ID: 24812155
[TBL] [Abstract][Full Text] [Related]
16. Renoprotective and antioxidative effects of methanolic Paederia foetida leaf extract on experimental diabetic nephropathy in rats.
Borgohain MP; Chowdhury L; Ahmed S; Bolshette N; Devasani K; Das TJ; Mohapatra A; Lahkar M
J Ethnopharmacol; 2017 Feb; 198():451-459. PubMed ID: 28111217
[TBL] [Abstract][Full Text] [Related]
17. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.
Mahfoz AM; El-Latif HA; Ahmed LA; Hassanein NM; Shoka AA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1315-1324. PubMed ID: 27612855
[TBL] [Abstract][Full Text] [Related]
18. A proteoglycan isolated from Ganoderma lucidum attenuates diabetic kidney disease by inhibiting oxidative stress-induced renal fibrosis both in vitro and in vivo.
Pan Y; Zhang Y; Li J; Zhang Z; He Y; Zhao Q; Yang H; Zhou P
J Ethnopharmacol; 2023 Jun; 310():116405. PubMed ID: 36966849
[TBL] [Abstract][Full Text] [Related]
19. Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat.
Lu HJ; Tzeng TF; Liou SS; Da Lin S; Wu MC; Liu IM
BMC Complement Altern Med; 2014 Mar; 14():110. PubMed ID: 24666993
[TBL] [Abstract][Full Text] [Related]
20. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M
Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
